Explore By Subject Area   

Lead Editorial

What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?

What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?

Novo Nordisk’s Real World Data Strategy Lead, Tom Dougherty, walks through clinical trial tokenization: where it is being used, why it’s such a potential value-add to trials and programs, and what life science organizations must consider when preparing for the inclusion of tokenization.

Read More

More Related Content

Editorial

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.